Results 51 to 60 of about 293,480 (309)
Introduction Access to smoking cessation treatment is limited in many countries. Digital tools could support healthcare professionals (HCPs) who have limited training and resources to deliver evidence-based cessation treatment to patients.
Aleksandra Herbeć +2 more
doaj +1 more source
Biopsychosocial Factors Associated with Successful Smoking Cessation in Surakarta, Central Java [PDF]
Background: Smoking is the leading preventable cause of death worldwide. Seventy percent of smokers would like to quit smoking, and 50 percent report attempting to quit within the past year.
Atmojo, J. T. (Joko) +2 more
core +1 more source
Antidepressants for smoking cessation [PDF]
There are at least three reasons to believe antidepressants might help in smoking cessation. Firstly, nicotine withdrawal may produce depressive symptoms or precipitate a major depressive episode and antidepressants may relieve these. Secondly, nicotine may have antidepressant effects that maintain smoking, and antidepressants may substitute for this ...
Hughes, JR +4 more
openaire +2 more sources
[18F]Fluorodeprenyl‐D2 PET as a Tool to Monitor Disease Activity in GAD65‐Ab Autoimmune Encephalitis
ABSTRACT Objective To evaluate [18F]fluorodeprenyl‐D2 ([18F]F‐DED) positron‐emission tomography (PET) imaging as a biomarker of disease activity in autoimmune encephalitis (AIE) associated with glutamic acid decarboxylase 65 (GAD65) antibodies. Methods [18F]F‐DED PET was performed in 25 GAD65‐AIE patients and 8 controls using dynamic (0–60 min) and ...
Julia S. Dorneich +19 more
wiley +1 more source
Introduction Aim: Smoking relapse is a frequent phenomenon, in which depressive symptoms, cigarette dependence, and craving play a significant role. Previous studies have shown that people with depressive symptoms have greater cigarette dependence and ...
Carmela Martinez-Vispo +4 more
doaj +1 more source
ABSTRACT Background and Purpose White matter hyperintensities (WMH) are a core neuroimaging marker of cerebral small vessel disease (CSVD). Sleep apnoea (SA) is a recognized vascular risk factor, but its associations with regional WMH burden, short‐interval WMH change and cognitive performance in population‐based cohorts remain incompletely defined. We
Peng Cheng +4 more
wiley +1 more source
Metabolic Changes Following Smoking Cessation in Patients with Type 2 Diabetes Mellitus
Background: Smoking cessation is crucial for reducing complications of type 2 diabetes mellitus (T2DM), but associated weight gain can worsen glycemic control, discouraging quitting attempts.
Stamatina Driva +8 more
doaj +1 more source
What is the quality of smoking cessation advice in guidelines of tobacco-related diseases? [PDF]
Smoking is a major risk factor for a range of diseases, and quitting smoking provides considerable benefits to health. It therefore follows that clinical guidelines on disease management, particularly for diseases caused by smoking, should include ...
Agrawal, Sanjay +5 more
core +1 more source
The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial [PDF]
Smoking cessation medications are effective but often underutilised because of costs and side effects. Cytisine is a plant-based smoking cessation medication with over 50 years of use in Central and Eastern Europe.
Boland, Veronica C. +19 more
core +1 more source
Associations of Rheumatoid Arthritis Disease Activity With Frailty Over Five Years of Follow‐up
Objective To evaluate whether rheumatoid arthritis (RA) disease activity is associated with frailty both in cross‐section and longitudinally. Methods Participants within the Veterans Affairs Rheumatoid Arthritis (VARA) registry enrolled from 2003 to 2022 were included.
Courtney N. Loecker +14 more
wiley +1 more source

